Jul 27, 2023 / 10:30AM GMT
Operator
Ladies and gentlemen, good day and welcome to the Ajanta Pharma Q1 FY2024 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Yogesh Agrawal, Managing Director of Ajanta Pharma Limited. Thank you, and over to you, sir.
Yogesh Agrawal - Ajanta Pharma Ltd. - MD
Thank you. Good evening, and welcome, all of you. With me, I have Mr. Rajesh Agrawal, our Joint Managing Director; Mr. Arvind Agrawal, our CFO; Mr. Rajeev Agrawal, our AVP, Finance & Investor Relations.
Friends, on July 9, we celebrated a significant milestone, the 50th anniversary of Ajanta Pharma. Today, our company stands strong and distinguished within the pharmaceutical industry. We have not only stood shoulder-to-shoulder with our leading companies, but we have also carved out our own unique mark of excellence.
Over the years we have built large brands across geographies, state-of-the-art research and development center, top-notch manufacturing facilities, robust quality systems,
Q1 2024 Ajanta Pharma Ltd Earnings Call Transcript
Jul 27, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers